Solanezumab Does Not Slow Cognitive Decline in Preclinical Alzheimer Disease
WEDNESDAY, July 19, 2023 (HealthDay News) — For patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in the New England Journal of Medicine to coincide with the annual…
Learn MoreJAK Inhibitors May Aid Hair Regrowth in Patients With Alopecia
WEDNESDAY, July 19, 2023 (HealthDay News) — Janus kinase (JAK) inhibitors are associated with more hair regrowth than placebo for patients with alopecia areata, according to a review published online June 27 in JAMA Network Open.Ming Liu, Ph.D., from…
Learn MoreOne-Hour Training Improves Documentation to Diagnose, Treat Tardive Dyskinesia
TUESDAY, July 18, 2023 (HealthDay News) — An annual one-hour Abnormal Involuntary Movement Score (AIMS) training session improves documentation to recognize and treat tardive dyskinesia in the psychiatry outpatient clinic, according to a study recent…
Learn MoreDonanemab Slows Clinical Progression in Early Alzheimer Disease
MONDAY, July 17, 2023 (HealthDay News) — Donanemab slows clinical progression among participants with early symptomatic Alzheimer disease and amyloid and tau pathology, according to a study published online July 17 in the Journal of the American Medi…
Learn MoreReguladores europeos investigan el riesgo de ideación suicida con unos populares fármacos para perder peso
MARTES, 11 de julio de 2023 (HealthDay News) — La Agencia Europea de Medicamentos (European Medicines Agency, EMA) está investigando preocupaciones de que Ozempic y Saxenda, unos populares medicamentos para perder preso, pudieran estar vinculados con…
Learn MoreTreatment Effect of Tofacitinib, Adalimumab Compared in RA
WEDNESDAY, July 12, 2023 (HealthDay News) — For adults with rheumatoid arthritis (RA), there is a modest reduction in the mean Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) at three months for patients receiving tofacitinib…
Learn MoreDeterminants of Overall Survival in Metastatic Uveal Melanoma Identified
WEDNESDAY, July 12, 2023 (HealthDay News) — Factors associated with improved survival in metastatic uveal melanoma include female sex and use of anti‐cytotoxic T lymphocyte-associated antigen (CTLA)‐4 and anti‐programmed cell death protein 1 (PD-1) t…
Learn MorePharmacy-Level Stewardship Can Save on Immune Checkpoint Inhibitors
TUESDAY, July 11, 2023 (HealthDay News) — Adoption of pharmacy-level stewardship strategies for immune checkpoint inhibitors could generate sizable reductions in spending for these drugs, according to a study published in the July issue of Health Aff…
Learn MoreEuropean Regulators Investigating Risk for Suicidal Thoughts With Popular Weight-Loss Drugs
TUESDAY, July 11, 2023 (HealthDay News) — The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm.Three case reports from Iceland spu…
Learn MoreRisk of Suicidal Thoughts With Popular Weight-Loss Drugs Being Investigated by European Regulators
TUESDAY, July 11, 2023 (HealthDay News) — The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm.Three case reports from Iceland spu…
Learn More